What was filed
Jagsonpal Pharmaceuticals told the exchanges it has fixed a record date to determine which shareholders qualify for its recommended final dividend for the year ended 31 March 2026. Under Regulation 42 of SEBI's LODR framework, only members on the register as of that date will be entitled to the payout. The same intimation confirms the company's 47th Annual General Meeting will be held on 18 September 2026 through video conferencing or other audio-visual means.
The dividend and the timeline
The Board recommended the dividend at its meeting on 27 April 2026, and it remains subject to shareholder approval at the AGM. If members approve it, the filing states the dividend is to be paid within 30 days of declaration, with applicable tax deducted at source. The company said the AGM Notice and Annual Report will be filed separately.